Other
Slowing vaccine demand to weigh on BioNTech profits
German vaccine-maker BioNTech said Monday its earnings would take a hit as demand for its coronavirus jab slowed.
Oct 16, 2023
0
0
News tagged with earnings
Other
Pfizer to acquire sickle cell drugmaker GBT for $5 bn
American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion.
Aug 8, 2022
0
3
Vaccination
Johnson & Johnson suspends sales forecast for COVID vaccine
Johnson & Johnson suspended sales forecasts for its COVID-19 vaccine during the American pharmaceutical giant's quarterly earnings call Tuesday, as demand lags behind that of shots by Moderna and Pfizer.
Apr 19, 2022
0
6
Oncology & Cancer
Study puts price tag on lost earnings from racial disparities in cancer mortality
A new American Cancer Society study puts a price tag on racial disparities in cancer mortality, finding that $3.2 billion in lost earnings would have been avoided in 2015 if non-Hispanic (NH) blacks had equal years of life ...
Jun 3, 2020
0
0
Medical economics
Drugmaker AstraZeneca warns on coronavirus impact
British pharmaceuticals group AstraZeneca on Friday warned that the coronavirus epidemic would hit its performance this year in key market China.
Feb 14, 2020
0
0
Other
Drugmaker Eli Lilly tops 2Q expectations, raises forecast
Eli Lilly raised its 2019 forecast after a jump in sales from the diabetes treatment Trulicity helped push the drugmaker to a better-than-expected second quarter.
Jul 30, 2019
0
0
Other
French pharma giant Sanofi says profits up in 2016
French pharmaceuticals giant Sanofi said Wednesday that cost-cutting measures and the strong performance of its rare diseases business drove up profits last year.
Feb 8, 2017
0
0
Other
UnitedHealth 4Q profit drops, still tops Street 4Q forecasts
UnitedHealth Group closed 2015 with a 19 percent drop in fourth-quarter profit, but the nation's largest health insurer still topped Wall Street's expectations thanks in part to growth outside of its core insurance business.
Jan 19, 2016
0
0
Other
Pfizer beats 3Q expectations, raises 2015 earnings forecast
Pfizer Inc., finally turning the corner after years of generic competition that slashed revenue from the drugmaker's former blockbusters, easily beat Wall Street expectations for the third quarter and raised its 2015 earnings ...
Oct 27, 2015
0
3
Other
Actavis plans name change to Allergan
Drugmaker Actavis is planning to change its name as it draws closer to finishing another big deal, the $66 billion purchase of Botox maker Allergan that it announced last fall.
Feb 18, 2015
0
2
